Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Eleanor Stride joins NDORMS as the new Professor of Biomaterials, leading the department’s vision in this area of research.

Eleanor is an internationally recognised researcher in medical engineering with pioneering work in biomaterials and their clinical applications, recognised as one of the 50 most influential women in Engineering in 2016.

Her research interests focus on applying engineering principles to solving clinical problems, specifically in drug delivery systems in engineering and biomedical ultrasonics.

Commenting on her appointment, Professor Stride says:

“I am very excited to join NDORMS and foster the genuine integration of engineering and medical research, maximising the benefits of the co-location with clinical researchers. Engineers have a different approach to problem-solving and that can be very useful for multidisplicinary questions. We are trained to analyse systems and solve problems. For me, solving clinical problems is as worthwhile as it gets."

At NDORMS, Eleanor is particularly keen to develop the concept of engineering delivery systems that actively modify the tissue environment to facilitate therapy.

“I believe there is enormous potential for exploiting the synergies between the work being carried out within the Institute of Biomedical Engineering on drug delivery and minimally invasive therapy, and the pioneering research on musculoskeletal and inflammatory conditions in the Botnar and Kennedy Institutes, at NDORMS”, says Professor Stride.QuoteEleanorStride.jpg

Eleanor and her team will bring together their expertise in the fabrication of agents and devices for stimuli responsive drug delivery with the state of the art models, and analytical and imaging techniques being developed at NDORMS.

The new interdisciplinary research theme she will develop in the department will focus on three key areas initially:

  1. Combining pharmaceutical and mechanostimulatory approaches to promote tissue repair;
  2. Investigating the role of inflammatory response in physically mediated drug delivery;
  3. Engineering systems for modulating tissue hypoxia.

Head of Department Professor Andrew Carr, says: “We are delighted to welcome Eleanor to NDORMS and deliver on our vision for biomaterials research, increasing the department’s capabilities in this relatively new field of research and continuing at the forefront of musculoskeletal research worldwide.”

Professor Stride holds a B.Eng. and Ph.D. from University College London. Following the completion of her PhD in 2005, she was appointed to a lectureship and a Royal Academy of Engineering and EPSRC Research Fellowship and subsequently a Readership in 2010. She joined the Institute of Biomedical Engineering in Oxford in October 2011, where she’s been leading an international multidisciplinary team since. Her work has led to the development of new patented technologies for the preparation of microbubble suspensions for ultrasound imaging and drug delivery and she has set up a spin-out company in this area.

She will hold a joint professorship with the Department of Engineering of the University of Oxford, at their Institute of Biomedical Engineering.

Similar stories

New Botnar Research Institute Director starts today

Professor Jonathan Rees begins his new role as Director of the Botnar Research Institute today, taking over from Professor Andrew Carr.

Patient and public involvement in Rheumatology research – embracing the wave of change

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

NDORMS joins research partnership to understand links between overlapping long-term conditions

The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Researchers show the role of cilia in cartilage health

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.